Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
about
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disordersModulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review.Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disordersAmygdala FAAH and anandamide: mediating protection and recovery from stressTranslational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorderFluoxetine Facilitates Fear Extinction Through Amygdala EndocannabinoidsImaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences.PTSD: from neurobiology to pharmacological treatmentsDiagnostic Biomarkers for Posttraumatic Stress Disorder: Promising Horizons from Translational Neuroscience ResearchEmerging drugs for the treatment of anxiety50 years of hurdles and hope in anxiolytic drug discoveryDevelopmental regulation of fear learning and anxiety behavior by endocannabinoids.Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate DiscussedAn Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical TrialsInteraction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retentionCannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing.Interactions between disordered sleep, post-traumatic stress disorder, and substance use disordersDeficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling.The Impact of Stress Hormones on Post-traumatic Stress Disorders Symptoms and Memory in Cardiac Surgery Patients.Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors.Organ-specific physiological responses to acute physical exercise and long-term training in humans.Clinical applications of hallucinogens: A review.Medical marijuana: more questions than answers.Metabolite profiling in posttraumatic stress disorder.Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder.Molecular Neuroimaging in Posttraumatic Stress Disorder.Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB.Neurobiological Interactions Between Stress and the Endocannabinoid System.Finding translation in stress research.Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.The rs1049353 polymorphism in the CNR1 gene interacts with childhood abuse to predict posttraumatic threat symptoms.Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats.Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD)Genetics as a molecular window into recovery, its treatment, and stress responses after strokePKCγ receptor mediates visceral nociception and hyperalgesia following exposure to PTSD-like stress in the spinal cord of rats.Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnessesLinking plasma cortisol levels to phenotypic heterogeneity of posttraumatic stress symptomatology.Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
P2860
Q22299116-0EA3AD40-ED82-41FA-9970-FA7986BD6C18Q26767636-1818AEC2-947B-4BD8-8F1C-88005F81E601Q27006437-DA4743E2-1CF0-45C5-9309-BA4795B47166Q27026443-BC902E34-F3E6-4147-AD75-C074A51A20AEQ27026926-8B55BE24-77E4-4589-8B26-E42E9E53B72BQ27310769-86EEF9A2-CC04-4310-B7EF-338AFE323047Q27321190-C56963ED-E81F-4B66-991A-A7A413B86BAEQ28070159-8A898155-C181-4C06-90D7-F653FFB022EAQ28082087-8EC8D91F-359E-4674-9B60-AE7A28FE9945Q28083141-15A657A4-10B8-41B8-8D11-02220B0EAD4AQ28297569-898436D1-D01E-4BDB-A248-9AB0DACAB85EQ30366747-544326AC-D067-4B3B-92EB-BC4FE047A553Q30366949-7D824D5A-636C-45DC-AF61-46602ECDEB57Q30375098-7B1EA513-5C81-48BD-8475-D7A288731B20Q30392035-8DF2FE45-4E7E-4FCD-A5B8-2399BE3C2A0CQ30400006-03A32394-CEE6-41E1-AC85-01F0AF5816D9Q33736941-77DB326B-B114-4681-A462-E3B2152DAF7EQ33772366-1CA40E00-311F-4085-BB05-12F64BFFB221Q33900638-95579202-9930-41F6-9D79-25BA457EDD9FQ34393055-CAEB487C-95A7-428E-8C11-715A6C7521CCQ34445824-6A7A33D5-E515-4329-985C-AC383C03805BQ34535259-BBEDCC75-6A36-47E9-A751-453333E4BFCFQ34570676-536F330C-FFA4-401F-B894-8E7AB231B102Q35200833-4CB10AE0-A12F-4323-ABF0-10F602E4E8BFQ35738226-C2DE1DD3-DB13-45FC-B27F-6012B074C026Q36019618-F4E3B7FF-DA71-4471-912E-770455725620Q36236067-057E00C9-AFA6-4BA5-AAA3-88BB73C44563Q36254356-5456E61A-F672-4616-8B81-B98C92CB67EAQ36366731-B7562051-849A-429D-9203-D54D532E1029Q36409621-CE9BB635-6BD5-4633-8179-4B5F92C6A291Q36417706-A69B4366-BF21-4E29-B2DB-391B9685803FQ36664783-71D3A73E-8FF3-470A-B532-03EF4E27FA16Q36690681-6A9CD711-A13B-413A-900A-A814271E69BDQ36945634-A39DF0CE-ACFD-4E18-A629-57AFCBCF344AQ37083923-9C9AD120-E775-42E8-BC6A-4CD96512EE84Q37088174-AC106A3E-6242-49EA-86BC-BC2C1954FD65Q37116261-5217615C-AE87-467D-A9CE-0CAD1F48F105Q37279826-76EB8E64-4539-46F6-A4E8-49767C95308AQ37349180-3A1966B6-A439-43EA-B1E8-304AB0AEF806Q37409877-731AC92A-B0C4-4006-AD4A-82D3D64FB5A6
P2860
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@ast
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@en
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@nl
type
label
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@ast
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@en
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@nl
prefLabel
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@ast
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@en
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Elevated brain cannabinoid CB1 ...... tron emission tomography study
@en
P2093
A Gujarro-Anton
A Neumeister
C R Bailey
D Piomelli
M N Potenza
R E Carson
R H Pietrzak
S Corsi-Travali
P2860
P2888
P304
P3181
P356
10.1038/MP.2013.61
P407
P577
2013-05-14T00:00:00Z